Charles Schwab
GNPX icon

Charles Schwab’s Genprex GNPX Stock Holding History

Charles Schwab’s Portfolio GNPX Stock Details GNPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1
Closed -$11.7K – 3549
2023
Q3 		$11.7K Hold
1
– – ﹤0.01% 3555
2023
Q2 		$28.2K Hold
1
– – ﹤0.01% 3516
2023
Q1 		$27.1K Hold
1
– – ﹤0.01% 3464
2022
Q4 		$43.1K Hold
1
– – ﹤0.01% 3389
2022
Q3 		$42K Hold
1
– – ﹤0.01% 3369
2022
Q2 		$42K Hold
1
– – ﹤0.01% 3416
2022
Q1 		$68K Buy
+1
New +$97.5K ﹤0.01% 3482
2021
Q3 		– Hold
0
– -$67K – 3521
2021
Q2 		– Sell
-2
Closed -$328K – 3330
2021
Q1 		$351K Hold
2
– – ﹤0.01% 3197
2020
Q4 		$338K Hold
2
– – ﹤0.01% 3112
2020
Q3 		$274K Buy
2
+1
+100% +$158K ﹤0.01% 3058
2020
Q2 		$194K Buy
+1
New +$122K ﹤0.01% 3173

Other funds holding GNPX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Charles Schwab's GNPX Position: Q4 2023 in Review

Charles Schwab sold out of Genprex (GNPX) in Q4 2023, closing a stake of 1 share — an estimated $11.7K sold.

Charles Schwab first reported a position in GNPX in Q2 2020 and held it in 11 quarters. The position peaked at $351K in Q1 2021. 20 funds tracked by Wall St. Rank hold GNPX as of Q4 2023.

  • Charles Schwab reported no remaining Genprex position as of Q4 2023 after selling out during the quarter.
  • Charles Schwab sold 1 Genprex share in Q4 2023, an estimated $11.7K.
  • Charles Schwab first reported a position in Genprex in Q2 2020 and held it in 11 quarters.
  • Charles Schwab's Genprex position peaked at $351K in Q1 2021.
  • 20 funds tracked by Wall St. Rank held Genprex as of Q4 2023.

Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.